Travis Tablet
Ranitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Mirae Bio Pharmaceutical Co., Ltd.
MFDS item code 201500084 · Approved 2015.01.08
This product's status changed to Expired on 2025.01.08. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of acid-related disorders (e.g., ulcers and gastritis); prevention of Mendelson syndrome
This medication is effective for ulcers occurring in the stomach and duodenum, gastritis, and conditions associated with excessive gastric acid secretion such as Zollinger-Ellison syndrome. It is also used for the treatment of gastroesophageal reflux disease and is administered prior to anesthesia to prevent Mendelson syndrome. It is helpful in treating ulcers that may occur after surgery or ulcers caused by nonsteroidal anti-inflammatory drugs (NSAIDs). It alleviates various gastrointestinal disorders, reducing patients' discomfort.
Usually, take 2 tablets by mouth twice daily, in the morning and at bedtime, regardless of meals. 1) Gastric and duodenal ulcers Take 2 tablets twice daily or 4 tablets once daily at bedtime. In particular, in patients with duodenal ulcers, a higher healing rate may be achieved by taking 4 tablets twice daily, in the morning and at bedtime. The same dosage applies to combination therapy for ulcers caused by nonsteroidal anti-inflammatory drugs (NSAIDs) or for prevention of gastric and duodenal ulcers during long-term NSAID use. Ulcers caused by NSAID use generally heal within 4 weeks, and other ulcers generally heal within 8 weeks, although healing may occasionally take longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 2 tablets once daily at bedtime as maintenance therapy. 2) Reflux esophagitis For 8 weeks, take 2 tablets twice daily or 4 tablets once daily at bedtime. For patients with severe reflux esophagitis, the dose may be increased to 4 tablets 4 times daily. 3) Zollinger-Ellison syndrome Start treatment with an initial dose of 2 tablets 3 times daily, and increase the dose if necessary. For severe disease, up to 6 g of ranitidine per day may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and give 2 tablets twice daily. 5) Premedication (prevention of Mendelson syndrome) Administer 2 tablets 2 hours before induction of anesthesia. In this case, it is preferable to also administer 2 tablets on the night before surgery.
This medication should not be used in patients receiving dialysis or those who have had allergic reactions to this drug or its components. Patients with a history of acute porphyria should also avoid this medication, and it is not safe to administer to patients with impaired kidney function or those who have recently undergone upper gastrointestinal surgery. This drug should not be administered to pregnant women or women who may become pregnant, neonates, and those on dietary restrictions limiting potassium intake. Patients with liver dysfunction, a history of drug allergies, elderly patients, or those with any kidney abnormalities should use this medication cautiously. Patients using nonsteroidal anti-inflammatory drugs should have regular checks, especially elderly patients or those with a history of peptic ulcers. Because this medication can mask symptoms of gastric cancer, it should only be administered to patients with gastric ulcers or newly appeared dyspeptic symptoms after confirming malignancy. Patients with Helicobacter pylori positive gastric and duodenal ulcers will need bacterial eradication treatment. Caution is necessary for severely ill patients, patients with hypophosphatemia, or those having difficulty swallowing when using this medication. During the use of this medication, allergic reactions may occur, including shock, skin rash, hives, and breathing difficulties; symptoms should be reported immediately and the medical personnel should be consulted. Blood tests may show decreased white blood cells or platelets; if symptoms such as fatigue, bleeding, or fever occur, tests should be conducted. Symptoms of liver dysfunction may develop, so jaundice or fatigue should be reported immediately. Cardiovascular abnormalities such as arrhythmias or vasculitis have been reported rarely, so caution is advised. Gastrointestinal symptoms such as nausea, vomiting, constipation, diarrhea, and abdominal distension may occur, and stools may turn black, but this usually does not require special treatment. In severely ill patients or the elderly, neurological abnormalities such as dizziness, drowsiness, confusion, or seizures may occur, necessitating observation. Muscle pain or joint pain may occur, and rarely severe muscle disorders like rhabdomyolysis can happen; report any unusual symptoms immediately. Skin rashes or hair loss may occur rarely. Avoid prolonged continuous use, and change to another medication if there is no therapeutic effect. In elderly patients or those with chronic conditions, there may be an increased risk of pneumonia, so caution is necessary. Avoid driving or operating dangerous machinery if experiencing dizziness or drowsiness while taking this medication. Use of this medication may interact with other drugs, so particularly when taken with anticoagulants, antibiotics, or anticonvulsants, consult with a healthcare professional. It is safest not to use this medication during pregnancy or breastfeeding. Safety in children has not been established, and its use is not advisable. This medication may affect some test results, so it is important to inform the medical staff during testing. In case of overdose, emergency procedures such as vomiting or gastric lavage may be needed, so caution is advised. This medication reduces gastric acid secretion, which could promote bacterial proliferation in the gastrointestinal tract; therefore, regular check-ups, including ocular examinations, are necessary with prolonged use.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air or moisture ingress, and it is best kept at room temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the medication's efficacy and prevent deterioration.
White round film-coated tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Ranitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Mirae Bio Pharmaceutical Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Nexpharm Korea Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
HUONS BioScience Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Daewoong Bio Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Teragen Etex Co., Ltd.
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Korea Pavise Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Kwangdong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.